Company intelligence / Profile preview

LUMA Vision

Dublin, Leinster, Irelandlumavision.com ↗

Ownership: Private
Development stage: Preclinical

Overview

The company’s VERAFEYE™ platform has received FDA clearance as of April 2025. First-in-human procedures have been completed successfully under the LUMINIZE clinical study. The system provides real-time, two-dimensional and four-dimensional intracardiac imaging with magnetic tracking capabilities for third-party catheters. It enables rapid CT-quality reconstructions of both atria in under a minute, supporting advanced electrophysiology interventions with improved precision.

Therapeutic areas: Cardiovascular
Modalities: DeviceUltrasound-based imaging platform
Industry: Medical Imaging

Partnerships

KDAB – software/UI development partner for the VERAFEYE project/software stack

Beyond the preview

Go deeper on LUMA Vision.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on LUMA Vision.

Explore the full profile